Session » Osteoporosis and Metabolic Bone Disease – Basic and Clinical Science Poster

Date: Tuesday, October 23, 2018

Time: 9:00AM-11:00AM

Meeting: 2018 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 2308

Abaloparatide for Risk Reduction of Nonvertebral and Vertebral Fractures in Postmenopausal Women with Osteoporosis: A Network Meta-Analysis

9:00AM-11:00AM: Abstract Number: 2319

Adherence to Guideline Recommendations for Screening and Treatment of Glucocorticoid Induced Osteoporosis in Patients with Rheumatoid Arthritis on Long Term Glucocorticoid Therapy at a Tertiary Care Center

9:00AM-11:00AM: Abstract Number: 2310

Association of Moderate/Severe Vertebral Fractures with Reduced Trabecular Volumetric Bone Density in Older Women and Reduced Areal Femoral Neck Bone Density in Older Men from Community: A Cross-Sectional Study (SPAH)

9:00AM-11:00AM: Abstract Number: 2329

Carotid Atherosclerosis Is Associated with Compromised Volumetric Bone Mineral Density and Microarchitecture in Patients with Inflammatory Arthritis

9:00AM-11:00AM: Abstract Number: 2317

Characterization of Paget´s Disease of Bone Patients from the South of Portugal (Algarve and Alentejo) – Clinical and Genetic Aspects

9:00AM-11:00AM: Abstract Number: 2300

Compliance with Screening and Supplementation Guidelines for Glucocorticoid-Induced Osteoporosis, How Bad Did We Do This Time?

9:00AM-11:00AM: Abstract Number: 2328

Current Factors Associated with Insufficient Vitamin D Status in Patients with Osteoporosis

9:00AM-11:00AM: Abstract Number: 2321

Dickkopf-1 Serum Levels in Patients with Systemic Sclerosis and Correlation with Trabecular Bone Score

9:00AM-11:00AM: Abstract Number: 2311

Effect of TNF Inhibitors on Bone Mineral Density in Rheumatoid Arthritis Patients Receiving Bisphosphonate

9:00AM-11:00AM: Abstract Number: 2316

Errors and Discrepancies in DXA Scans in Imaging Centers in Ecuador

9:00AM-11:00AM: Abstract Number: 2302

Forearm Bone Mineral Density and Fracture Incidence in Postmenopausal Women with Osteoporosis

9:00AM-11:00AM: Abstract Number: 2318

Fracture Liaison Service in an Open Health System: Outcomes and Challenges

9:00AM-11:00AM: Abstract Number: 2333

High Serum Uric Acid Protects Against Osteoporosis in Postmenopausal Women: Data from the Korean National Health and Nutrition Examination Survey

9:00AM-11:00AM: Abstract Number: 2336

Identification of Osteoporosis As a Reason for Vertebral Fractures in Patients with Rheumatoid Arthritis and Non-Inflammatory Musculoskeletal Diseases – a Comparison between Trabecular Bone Score (TBS) and Bone Mineral Density (BMD)

9:00AM-11:00AM: Abstract Number: 2309

Implementation of a Primary Prevention, Population-Based Virtual Osteoporosis Clinic Dramatically Increases the Number of Rural Veterans Receiving Osteoporosis Screening and Treatment

9:00AM-11:00AM: Abstract Number: 2304

Implication of Bone Turnover Marker Follow-up during Antiresorptive Therapy in Patients with Active Rheumatoid Arthritis on Immunosuppresssive Agents

9:00AM-11:00AM: Abstract Number: 2307

In the 21st Century: Is Still Rheumatoid Arthritis a Risk Factor for Osteoporotic Fractures?

9:00AM-11:00AM: Abstract Number: 2322

Intervals of Bone Mineral Density Measurement during Treatment for Osteoporosis in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2320

Multimorbidity Is Associated with Hip Fractures in Both Women and Men and across Different Races

9:00AM-11:00AM: Abstract Number: 2331

Obesity Might Positively Affect TNF Mediated Bone Metabolism in RA Patients

9:00AM-11:00AM: Abstract Number: 2315

Opportunistic Screening for Osteoporosis Using Thoraco-Abdomino-Pelvic Computed Tomography Assessing the Vertebral Density in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 2335

Osteoporotic Fracture Trends in a Population of US Managed Care Enrollees: 2007-2017

9:00AM-11:00AM: Abstract Number: 2326

Outcomes One Year after Hip Fracture Repair in the Elderly: Does Social Isolation Matter?

9:00AM-11:00AM: Abstract Number: 2305

Peripheral Arterial Disease Is Associated with an Increased Risk of Subsequent Hip Fracture: A Systematic Review and Meta-Analysis of Cohort Studies

9:00AM-11:00AM: Abstract Number: 2323

Predictors of Mortality in Patients with Hip Fragility Fracture

9:00AM-11:00AM: Abstract Number: 2324

Predictors of Refracture in Patients with Hip Fragility Fracture

9:00AM-11:00AM: Abstract Number: 2314

Ratio of BMI to BMD at Different Sites and Association with Fragility Fractures

9:00AM-11:00AM: Abstract Number: 2303

Response Rates for Hip, Femoral Neck, and Lumbar Spine Bone Mineral Density in Patients Treated with Abaloparatide Followed By Alendronate

9:00AM-11:00AM: Abstract Number: 2332

Rheumatoid Arthritis Effect´s on Bone Mass and Muscle

9:00AM-11:00AM: Abstract Number: 2325

Sex Differences in the Association of Frailty and Bone Mineral Density in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2312

Spontaneous Vertebral Fractures after Denosumab Discontinuation

9:00AM-11:00AM: Abstract Number: 2299

Subgroup Analysis of the Effect of Denosumab Compared with Risedronate on Percentage Change in Lumbar Spine Bone Mineral Density at 24 Months in Glucocorticoid-Treated Individuals

9:00AM-11:00AM: Abstract Number: 2306

The Association of Dietary Amino Acids with Incident Hip Fracture, BMD and Body Composition. the Cardiovascular Health Study

9:00AM-11:00AM: Abstract Number: 2313

The Efficacy of Denosumab for Prevention of Osteoporotic Fractures in Patients with Connective Tissue Diseases Receiving Very High Doses of Glucocorticoid

9:00AM-11:00AM: Abstract Number: 2327

To Screen or Not to Screen?Dexa Ordering Patterns in SLE Patients Who Take Systemic Glucocorticoids

9:00AM-11:00AM: Abstract Number: 2301

Trend of Osteoporosis and Osteoporotic Fragility Fractures Among Select Autoimmune Rheumatologic Diseases: Results from National Inpatient Sample

9:00AM-11:00AM: Abstract Number: 2337

Vertebral Compression Fractures and Antibodies to Citrullinated Vimentin in Established Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2330

Vitamin D and Bisphosphonate Therapy in SLE Patients Who Receive Glucocorticoids: Are We Offering the Best Care?

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].